|
gptkbp:instance_of
|
gptkb:software
|
|
gptkbp:bfsLayer
|
4
|
|
gptkbp:bfsParent
|
gptkb:Pfizer_Inc.
gptkb:Warner-Lambert
gptkb:Upjohn
|
|
gptkbp:approves
|
gptkb:FDA
|
|
gptkbp:brand
|
atorvastatin calcium
|
|
gptkbp:class
|
HMG-Co A reductase inhibitors
|
|
gptkbp:clinical_trial
|
gptkb:TNT
JUPITER
ASCOT-LLA
SPARCL
|
|
gptkbp:contraindication
|
liver disease
pregnancy
|
|
gptkbp:counseling_services
|
avoid alcohol
take at the same time each day
report unexplained muscle pain
|
|
gptkbp:diet
|
low-fat diet
low-cholesterol diet
|
|
gptkbp:dosage_form
|
gptkb:tablet
|
|
gptkbp:formulation
|
film-coated tablet
|
|
gptkbp:has_ability
|
10 mg
20 mg
80 mg
40 mg
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Lipitor
|
|
gptkbp:ingredients
|
gptkb:atorvastatin
|
|
gptkbp:interacts_with
|
gptkb:beer
gptkb:HIV_protease_inhibitors
certain antibiotics
antifungal medications
|
|
gptkbp:invention
|
gptkb:2011
|
|
gptkbp:is_available_on
|
combination therapy
oral tablet
|
|
gptkbp:is_monitored_by
|
liver function tests
lipid levels
|
|
gptkbp:is_used_for
|
lowering cholesterol
|
|
gptkbp:manufacturer
|
gptkb:Pfizer
|
|
gptkbp:marketed_as
|
gptkb:legislation
gptkb:1997
gptkb:Australia
gptkb:Japan
gptkb:United_States
gptkb:Native_American_tribe
|
|
gptkbp:previous_name
|
gptkb:battle
|
|
gptkbp:replaced_by
|
gptkb:battle
|
|
gptkbp:requires
|
prescription only
|
|
gptkbp:side_effect
|
fatigue
headache
muscle pain
nausea
liver damage
joint pain
digestive problems
increased blood sugar
|
|
gptkbp:storage
|
room temperature
away from moisture
away from light
|
|
gptkbp:treatment
|
hyperlipidemia
preventing cardiovascular disease
|